The future of mRNA cancer immunotherapies is uncertain after Health and Human Services Secretary Robert F. Kennedy Jr. defunded 22 mRNA vaccine projects for flu and COVID-19.

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

Researchers plan to collaborate on preclinical trials to apply polymersomes to real-world vaccine or drug delivery challenges.

The Barcelona Institute for Global Health (ISGlobal) has launched HTGAnalyzer, a new, easy-to-use, fast and reproducible ...

CureVac (CVAC) and GSK (GSK) to receive $740M and other payments in a settlement with Pfizer (PFE) and BioNTech (BNTX) over ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

When COVID-19 cases were surging, Dr. David Wohl saw patients “hungry for air” fill UNC hospital wards. What most saved lives ...

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

In his ongoing crusade to make America sicker, Health Secretary Robert F. Kennedy Jr. has axed about $500 million in mRNA vaccine research funding.

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...